NASDAQ:EXOZ eXoZymes Q3 2026 Earnings Results & Report $3.44 -0.55 (-13.68%) Closing price 03:55 PM EasternExtended Trading$3.45 +0.00 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. eXoZymes reported Q3 2026 earnings on November 13, 2026. The company reported EPS of -$0.24. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 13, 2026TimeAfter Market ClosesConference Call DateNovember 19, 2026Conference Call5:00 PM ET eXoZymes EPS ResultsActual EPS-$0.24Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AeXoZymes Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) eXoZymes Q3 2026 Earnings FAQ Did eXoZymes beat earnings estimates for Q3 2026? eXoZymes (NASDAQ:EXOZ) reported earnings of -$0.24 per share for Q3 2026. The report was announced on Friday, November 13, 2026. eXoZymes Earnings HeadlinesReviewing eXoZymes (NASDAQ:EXOZ) and Upstream Bio (NASDAQ:UPB)November 16 at 2:15 AM | americanbankingnews.comeXoZymes Highlights Investor Presentation for Capital Markets OutreachOctober 9, 2026 | tipranks.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 17 at 1:00 AM | Base Camp Trading (Ad)eXoZymes Completes New Securities Offering to Fund PipelineJuly 1, 2026 | tipranks.comeXoZymes Secures NIH Grant to Advance Cannabinoid PipelineJune 26, 2026 | tipranks.comeXoZymes Completes Nasdaq Equity Offering to Fund PipelineJune 17, 2026 | tipranks.comSee More eXoZymes Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like eXoZymes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on eXoZymes and other key companies, straight to your email. Email Address About eXoZymeseXoZymes (NASDAQ:EXOZ) is a biotechnology company focused on cell-free biomanufacturing. Its approach uses enzymes outside living cells to produce compounds, offering an alternative to conventional manufacturing methods. The company’s work centers on developing its biomanufacturing platform and applying it to the production of useful molecules. Publicly available information about specific commercial products, customer markets, geographic reach and company leadership is limited.View eXoZymes ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.